Key result
MMP-3 6A/6A genotype is linked to increased risk of coronary lesions in Kawasaki disease.
Case-Control (n=83)
No
Answers are grounded in this paper and cite their sources.
Kawasaki disease (KD) is a major cause of acquired coronary artery diseases in childhood. The serum levels of matrix metalloproteinase (MMP)-3 and MMP-9 in KD have been reported to be significantly higher than other diseases. Several studies have demonstrated that MMP-3 5A/6A polymorphism and MMP-9 C-1562T polymorphism modify each transcriptional activity in allele specific manner. We hypothesized that these polymorphisms may play a role as a risk factor for development of coronary artery lesions (CAL) in KD. Eighty-three patients, diagnosed with KD in Cheju National University Hospital from January 2000 to February 2004, were divided into two groups according to the presence of CAL. Genotyping of MMP-3 and MMP-9 gene polymorphisms were determined by restriction fragment length polymorphism. With regard to MMP-3 gene polymorphism, the KD with CAL group had a higher frequency of 6A/6A genotype than control group (p=0.0127) and the KD without CAL group (p=0.0036). However, no significant differences in the allele and genotype distributions of the MMP-9 polymorphism were observed. These findings suggest that MMP-3 6A/6A genotype may be an independent risk factor for CAL formation in KD.
No takes yet. Share an insight, caveat, or question.
Park et al. (2005) conducted a case-control in Kawasaki disease (n=83). MMP-3 5A/6A and MMP-9 C-1562T gene polymorphisms vs. Control group and Kawasaki disease patients without coronary artery lesions was evaluated on Development of coronary artery lesions (CAL) (p=0.0036). The MMP-3 6A/6A genotype was more frequent in Kawasaki disease patients with coronary artery lesions than in those without and controls.
Synapse has enriched 10 related papers. Consider them for comparative context: